This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: Ainnocence Technologies LLC, Shanghai Abelzeta Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Junfeng Wu in Drug Screening Technologies
Introduction
Junfeng Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of drug screening technologies. With a total of 4 patents, his work focuses on enhancing the efficiency and accuracy of drug discovery processes.
Latest Patents
Wu's latest patents include a ligand screening model construction method and device. This invention involves a comprehensive approach to drug screening, utilizing a drug ligand training set that includes chemical formulas and classification labels. The method employs a ligand graph network where atoms are represented as nodes and chemical bonds as edges. By using deep learning techniques, Wu's model aims to improve the identification of potential drug candidates.
Another notable patent is the PROTAC target molecule generation method, which includes a computer system and storage medium. This method extracts target protein ligand structures and combines them with degradation agent and linker fragment structures. The innovative approach enhances molecular design accuracy and accelerates drug research and development processes.
Career Highlights
Throughout his career, Junfeng Wu has worked with several companies, including Ainnocence Technologies LLC and Shanghai Abelzeta Ltd. His expertise in drug screening technologies has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Wu has collaborated with notable professionals in his field, including Yutong Jin and Lurong Pan. These partnerships have contributed to the advancement of his innovative projects and patents.
Conclusion
Junfeng Wu's contributions to drug screening technologies demonstrate his commitment to improving the pharmaceutical landscape. His innovative patents and collaborative efforts highlight the importance of advancements in drug discovery.